Oligo Factory
Jason Morrissey has a diverse range of work experience in the senior living industry. Jason is currently working as an Operations Manager at Oligo Factory since January 2022. Prior to that, they served as an Executive Director at HALLKEEN ASSISTED LIVING COMMUNITIES, LLC from March 2021 to September 2021. Jason also worked at Senior Living Residences from November 2016 to March 2021, first as a Business Administration Specialist and then as the Director of Business Affairs. Jason was previously employed at EPOCH Senior Living as a Business Office Manager from July 2012 to November 2016. Jason also worked at Benchmark Senior Living as the Director of Community Relations from November 2011 to July 2012. Additionally, they served as an Assistant Property Manager at HallKeen Management from August 2010 to November 2011 and worked as JM Realty Management at Boston portfolio from December 2009 to July 2010.
Jason Morrissey attended Bridgewater State University from 1995 to 1997. Jason then went on to study at Framingham State University from 2010 to 2012, although the degree obtained and field of study pursued are not specified.
This person is not in any teams
Oligo Factory
Oligo Factory is a leader in DNA/RNA oligonucleotide synthesis at scale. We were founded in 2006 by individuals with expertise in oligo synthesis technology as well as the oligo service business. The company’s goal was and is to provide oligonucleotides, high-quality purified DNA and RNA, at medium- to large-scale quantities to the research and life science communities. The Oligo Factory team is made up of skilled chromatographers, synthesis chemists, instrumentation engineers and commercialization specialists with more than 60 yrs of combined experience. We pride ourselves on service, cost-effective product delivery and attention to detail bc that’s what our customers need and deserve. We continue to invest in people and technology to serve the growing demands of scientific discoveries. We are dedicated to providing the highest quality oligonucleotides that drive a better future for humankind.